Dr. Samer Homsi, MD

Dr. Homsi practices at St Vincent Infirmary Medical Center in Little Rock, Arkansas.

Dr. Homsi's NPI, 1366604902, was assigned on June 25, 2008. Dr. Homsi holds Arkansas license E5566.

Dr. Homsi's primary practice is St Vincent Infirmary Medical Center, at 10001 Lile Dr, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 227-8000.

Dr. Homsi's primary practice is St Vincent Infirmary Medical Center in Little Rock, Arkansas. Dr. Homsi is also affiliated with CHI St. Vincent Infirmary. The medical group on file is CHI St. Vincent Medical Group. Dmand AI also links Dr. Homsi to 4 more hospitals, 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Homsi practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Homsi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Homsi is licensed in Arkansas.

CMS data shows 3,902 Medicare services from Dr. Homsi across 27 procedure codes in 2024, for 979 Medicare patients. Medicare paid $189,720 for them.

CMS counts 979 Medicare patients who saw Dr. Homsi in 2024. The largest group is 75 to 84, with 422 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Homsi's median patient age at 73, with 57% women.

In 2024, Dr. Homsi wrote 1,878 Medicare Part D claims for 299 patients. 57% of them were for generic drugs. CMS names the drug for 1,629 of them, across 34 drugs with 11 or more claims each, at $709,587 in total drug cost. In 2023, CMS named 1,825 claims across 39 drugs.

Dr. Homsi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Homsi as offering telehealth.

Dmand AI links 6 papers to Dr. Homsi in 2010. The most frequent topics are Influenza A Virus, H1N1 Subtype, Influenza, Human and Lung Neoplasms. Dr. Homsi has published most often in J Ark Med Soc. Dr. Homsi's most frequent co-authors are Yamen Marhaf Homsi, MD, Constantin Dasanu, MD, PhD and Wissam B. Abouzgheib, MD.

CMS Open Payments shows 995 general payments to Dr. Homsi from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. GlaxoSmithKline, LLC. paid the most, $3,730.